We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
95 hedge funds and large institutions have $27.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 20 increasing their positions, 34 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
3,650% more call options, than puts
Call options by funds: $75K | Put options by funds: $2K
15% less funds holding
Funds holding: 112 → 95 (-17)
24% less capital invested
Capital invested by funds: $36.7M → $27.9M (-$8.77M)
41% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 34
89% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 19
Holders
95
Holders Change
-17
Holders Change %
-15.18%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
20
Reduced
34
Closed
19
Calls
$75K
Puts
$2K
Net Calls
+$73K
Net Calls Change
-$71K
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$117K |
| 2 |
Morgan Stanley
New York
|
+$60.3K |
| 3 |
JP Morgan Chase
New York
|
+$56.3K |
| 4 |
Renaissance Technologies
New York
|
+$53.4K |
| 5 |
Barclays
London,
United Kingdom
|
+$22K |
Top Sellers
| 1 |
BlackRock
New York
|
-$273K |
| 2 |
Millennium Management
New York
|
-$176K |
| 3 |
Jane Street
New York
|
-$116K |
| 4 |
E
Ergoteles
New York
|
-$83.8K |
| 5 |
HF
HRT Financial
New York
|
-$82K |
